A phenotype survey of 36 mutant mouse strains with gene-targeted defects in glycosyltransferases or glycan-binding proteins

Glycobiology

Volumn 23, Issue 3, 2013, Pages 363-380

  Orr, Sally L ^e   Le, Dzung ^a   Long, Jeffrey M ^c   Sobieszczuk, Peter ^d   Ma, Bo ^b   Tian, Hua ^b   Fang, Xiaoqun ^b   Paulson, James C ^b   Marth, Jamey D ^e   Varki, Nissi ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Glycan binding protein; Glycosyltransferase; Homozygous mutant mice; Knock out mice; Mouse phenotype

Indexed keywords

BINDING PROTEIN; ECALECTIN; FUCOSYLTRANSFERASE; FUCOSYLTRANSFERASE 2; GALECTIN 2; GALECTIN 3; GLYCAN; GLYCAN BINDING PROTEIN; GLYCOSYLTRANSFERASE; LANGERIN; LECTIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING; GENETIC SCREENING; GLYCOBIOLOGY; HEMATOLOGY; HISTOLOGY; IMMUNOLOGY; METABOLISM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; WILD TYPE;

ANIMALS; GENE TARGETING; GLYCOSYLTRANSFERASES; HOMOZYGOTE; LECTINS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MUTATION; PHENOTYPE;

MUS;

EID: 84875693400     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cws150     Document Type: Article

References (51)

1. Abbott KL, Troupe K, Lee I, Pierce M. 2006. Integrin-dependent neuroblastoma cell adhesion and migration on laminin is regulated by expression levels of two enzymes in the O-mannosyl-linked glycosylation pathway, PomGnT1 and GnT-Vb. Exp Cell Res. 312(15):2837-2850.
2. Akita K, von Holst A, Furukawa Y, Mikami T, Sugahara K, Faissner A. 2008. Expression of multiple chondroitin/dermatansulfotransferases in the neurogenic regions of the embryonic and adult central nervous system implies that complex chondroitin sulfates have a role in neural stem cell maintenance. Stem Cells. 26(3):798-809.
3. Balch SG, Greaves DR, Gordon S, McKnight AJ. 2002. Organization of the mouse macrophage C-type lectin (Mcl) gene and identification of a subgroup of related lectin molecules. Eur J Immununogenet. 29:61-64. (Pubitemid 34146662)
4. Barthold SW. 2004. Genetically altered mice: Phenotypes, no phenotypes, and faux phenotypes. Genetica. 122:75-88. (Pubitemid 39459527)
5. Brayton C, Justice M, Montgomery CA. 2001. Evaluating mutant mice: Anatomic pathology. Vet Pathol. 38:1-19. (Pubitemid 33621668)
6. Brown S, Lad H, Green E, Gkoutos G, Gates H, Hrabe de Angelis M. 2006. EUMORPHIA and the European mouse phenotyping resource for standardized screens (EMPReSS). In: DeAngelis MH, Chambon P, Brown S, editors. Standards of Mouse Model Phenotyping. Weinheim Wiley-VCH. p. 311-320.
7. Brynedal B, Wojcik J, Esposito F, Debailleul V, Yaouang J, Martinelli-Boneschi F, Comi E, Hillert J, Abderrahim H. 2010. MGAT5 alters the severity of multiple sclerosis. J Neuroimmunol. 220:120-124.
8. Cardiff RD. 2007. Pathologists needed to cope with mutant mice. Nature. 447:528. (Pubitemid 46868028)
9. Chang SY, Kweon MN. 2010. Langerin-expressing dendritic cells in gut-associated lymphoid tissues. Immunol Rev. 234:233-246.
10. Crawley JN. 2007. What's Wrong With My Mouse? Wiley and Sons.
11. Ding JX, Xu LX, Zhu L, Lv JC, Zhao MH, Zhang H, Wang HY. 2009. Activity of α2,6-sialyltransferase and its gene expression in peripheral B lymphocytes in patients with IgA nephropathy. Scand J Immunol. 69:174-180.
12. Domino SE, Zhang L, Gillespie PJ, Saunders TL, Lowe JB. 2001. Deficiency of reproductive tract alpha(1,2)fucosylated glycans and normal fertility in mice with targeted deletions of the FUT1 or FUT2 alpha(1,2)f ucosyltransferase locus. Mol Cell Biol. 24:8336-8345. (Pubitemid 33108594)
13. Fujikado N, Saijo S, Yonezawa T, Shimamori K, Ishii A, Sugai S, Kotaki H, Sudo K, Nose M, Iwakura Y. 2008. Dcir deficiency causes development of autoimmune diseases in mice due to excess expansion of dendritic cells. Nat Med. 14:176-180. (Pubitemid 351214549)
14. Geijtenbeek TBH, Torensma R, van Vliet SJ, van Duijnhoven GCF, Figdor CG. 2000. Identification of DC-SIGN, a novel dendritic-cell specific ICAM-3 receptor that supports primary immune responses. Cell. 100:575-585.
15. Geijtenbeek TBH, Groot PC, Noite MA, van Vliet SJ, Gangaram-Pandey ST, van Duijnhoven GCF, Kraal G, van Oosterhout AJM, van Kooyk Y. 2002. Marginal zone macrophages express a murine homolog of DC-SIGN that captures blood-borne antigens in vivo. Blood. 8(100):2908-2916.
16. Granovsky M, Fata J, Pawling J, Muller WJ, Khokha R, Dennis JW. 2000. Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat Med. 6:306-312. (Pubitemid 30148623)
17. Harregui JM, Bianco GA, Toscano MA, Rabinovich GA. 2005. The coming of age of galectins as immunomodulatory agents: Impact of these carbohydrate binding proteins in T cell physiology and chronic inflammatory disorders. Ann Rheum Dis. 64:96-103.
18. Heidari Y, Bygrave AE, Rigby RJ, Rose KL, Walport MJ, Cook HT, et al. 2006. Identification of chromosome intervals from 129 and C57BL/6 mouse strains linked to the development of systemic lupus erythematosus. Genes Immun. 7:592-599. (Pubitemid 44614874)
19. Hickmann-Davis JM. 2001. Implications of mouse genotype for phenotype. News Physiol Sci. 16:19.
20. Hirashima M, Kashio Y, Nishi N, Yamauchi A, Imaizumi TA, Kageshita T, Saita N, Nakamura T. 2004. Galectin-9 in physiological and pathological conditions. Glycoconj J. 19:593-600. (Pubitemid 38460942)
21. Homeister JW, Thall AD, Petryniak B, Maly P, Rogers CE, Smith PL, Kelly RJ, Gersten KM, Askari SW, Cheng G, Smithson G, Marks RM, Misra AK, Hindsgaul O, von Andrian UH, Lowe JB. 2001. The alpha(1,3) fucosyltransferasesFucT-IV and FucT-VII exert collaborative control over selectin-dependent leukocyte recruitment and lymphocyte homing. Immunity. 15(1):115-126. (Pubitemid 32728325)
22. Ichikawa S, Sorenson AH, Austin AM, Mackenzie DS, Fritz TA, Moh A, Hui SL, Econs MJ. 2009. Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expression. Endocrinology. 150(6):2543-2550.
23. Inamori K, Endo T, Ide Y, Fujil S, Gu J, Honke K, Taniguchi N. 2003. Molecular cloning and characterization of human GnT-IX, a novel beta1,6-N-acetylglucosaminyltransferase that is specifically expressed in the brain. J Biol Chem. 278(44):43102-43109. (Pubitemid 37345927)
24. Jelcick AS, Yuan Y, Leehy BD, Cox LC, Sileira AS, Qiu F, Schenk S, Sachs AJ, Morrison MA, Nystuen AM, DeAngelis MM, Haider NB. 2011. Genetic Variations Strongly Influence Phenotypic Outcome in the Mouse Retina. PLoS One. 6(7):e21858.
25. Kiernan JA. 2001. Histological and Histochemical methods: Theory and Practice. 3rd ed. London (UK): A Hodder Arnold Publication.
26. Kile BT, Mason-Garrison CL, Justice MJ. 2003. Sex and strain-related differences in the peripheral blood cell values of inbred mouse strains. Mamm Genome. 14:81-85. (Pubitemid 36132589)
27. Kiselycznyk C, Holmes A. 2011. All (C57BL/6) mice are not created equal. Frontiers in Neuroscience. 4:29.
28. Koppel EA, van Glsbergen KPJM, Geijtenbeek TH, van Kooyk Y. 2005. Distinct functions of DC-SIGN and its homologues mSignR1, in pathogen recognition and immune regulation. Cellular Microbiology. 7(2): 157-165. (Pubitemid 40259732)
29. Lau K, Partridge EA, Silvescu CI, Grigorian A, Pawling J, Reinhold VN, Demetriou M, Dennis JW. 2007. Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell. 129:123-124.
30. Liu F-T, Rabinovich GA. 2005. Galectins as modulators of tumor progression. Nature Reviews. 5:29-41.
31. Loser K, Sturm A, Voskort M, Kupas V, Balkow S, Aurenmma M, Sternemann C, Dignass AU, Luger TA, Beissert S. 2009. Galectin-2 suppresses contact allergy by inducing apoptosis in activated CD8+ T cells. J Immunol. 182(9):5419-5429.
32. Lowe JB, Marth JD. 2003. A Genetic Approach to Mammalian Gene Function. Annu Rev Biochem. 72:643-691. (Pubitemid 36930456)
33. Maly P, Thall A, Petryniak B, Rogers CE, Smith PL, Marks RM, Kelly RJ, Gersten KM, Cheng G, Saunders TL, Camper SA, Camphausen RT, Sullivan FX, Isogai Y, Hindsgaul O, von Andrian UH, Lowe JB. 1996. The alpha(1,3) fucosyltransferaseFuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis. Cell. 86(23):643-653. (Pubitemid 26299495)
34. Manya H, Sakai K, Kobayashi K, Taniguchi K, Kawakita M, Toda T, Endo T. 2003. Loss-of-function of an N-acetylglucosaminyltransferase POMGnT1 in muscle-eye-brain disease. Biochem Biophys Res Comm. 1(306):93-97. (Pubitemid 36629409)
35. Marcos NT, Pinho S. 2004. Role of the human ST6GalNAc-1 and ST6GalNAc-II in the synthesis of the cancer associated sialyl-Tn antigen. Cancer Res. 64:7050-7057. (Pubitemid 39331016)
36. Maronpot RR, Boorman GA, Gaul BW. 1999. Pathology of the mouse. Vienna (IL): Cache River Press.
37. Martin LT, Marth JD, Varki A, Varki NM. 2002. Genetically altered mice with different sialyltransferase deficiencies show tissue-specific alterations in sialylation and sialic acid 9-0-acetylation. J Biol Chem. 277: 32930-32938. (Pubitemid 34987555)
38. Matsuno H, Okada K, Ueshima S, Matsuo O, Kozawa O. 2003. Alpha2-antiplasmin plays a significant role in acute pulmonary embolism. J Thromb Haemost. 1:1734-1739.
39. Miyagoe-Suzuki Y, Masubuchi N, Miyamoto K, Wada MR, Yuasa S, Saito F, Matsumura K, Kanesaki H, Kudo A, Manya H, Endo T, Takeda S. 2009. Reduced proliferative activity of POMGnT1-null myoblasts in vitro. Mech Dev. 126(3-4):107-116.
40. Mizuochi S, Akimoto Y, Imai Y, Hirano H, Irimura T. 1997. Unique tissue distribution of a mouse macrophage C-type lectin. Glycobiology. 1(7):137-146. (Pubitemid 27091328)
41. Moran JL, Shifley ET, Levorse JM, Mani S, Ostmann K, Perez-Balaguer A, Walker DM, Vogt TF, Cole SE. 2009. Manic fringe is not required for embryonic development and fringe family members do not exhibit redundant functions in the axial skeleton, limb, or hindbrain. Dev Dyn. 238:1803-1812.
42. Morgan R, Gao G, Pawling J, Dennis JW, Demetriou M, Li B. 2004. N-Acetylglucosaminyltransferase V (Mgat5)-mediated N-glycosyltaion negatively regulated Th1 cytokine production by T cells. J Immunol. 173:7200-7208. (Pubitemid 39628155)
43. Nagaoka K, Takaharav K, Minamino K, Takeda T, Yoshida Y, Inaba K. 2010. Expression of C-type lectin, SIGNR3, on subsets of dendritic cells, macrophages and monocytes. J Leukocyte Biol. 88(5):913-924.
44. Ohtsubo K, Marth JD. 2006. Glycosylation in cellular mechanisms of health and disease. Cell. 126:855-867. (Pubitemid 44310784)
45. Ohtsubo K, Takamatsu S, Minowa MT, Yoshida A, Takeuchi M, Marth JD. 2005. Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes. Cell. 123:1307-1321. (Pubitemid 41821787)
46. Okada K, Ueshima S, Imano M, Kataoka K, Matsuo O. 2004. The regulation of liver regeneration by the plasmin/alpha 2-antiplasmin system. J Hepatol. 40:110-116. (Pubitemid 38064719)
47. Onami TM, Lin MY, Varki NM, Page DM, Marth JD, Reynolds S, Katayama CD, Irimura T, Varki A, Hedrick SM. 2002. Generation of mice mutant for the macrophage galactose and N-acetylgalactosamine-specific lectin: Limited role in lymphoid and erythroid homeostasis and evidence for multiple lectins. Mol Cell Biol. 22:5173-5181. (Pubitemid 34700706)
48. Osorio F, Reis e Sousa C. 2011. Myeloid C-type lectin receptors in pathogen recognition and host defense. Immunity. 34:651-664.
49. Raman R, Venkatraman M, Ramakrishnan S, Lang W, Raguram S, Sasisekharan R. 2006. Advancing glycomics: Implementation strategies at the Consortium for Functional Glycomics. Glycobiology. 5:82-90.
50. Romani N, Clausen BE, Stoltzner P. 2010. Langerhans cell and more: Langerin-expressing dendritic cell subsets in the skin. Immunol Rev. 234:120-141.
51. Speradino M, Gleissner CA, Ley K. 2009. Glycosylation in immune cell trafficking. Immunol Rev. 230(1):97-113.